Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
about
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.Molecular approaches to thyroid cancer diagnosis.Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.Single-center study of familial papillary thyroid cancer in China: surgical considerations.Controversies in familial thyroid cancer 2014Familial papillary thyroid carcinoma: a retrospective analysis.The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic casesGermline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.Trends in Thyroid Cancer Incidence in Korean Children (1999-2012) Based on Palpation and Nonpalpation Detection Methods.Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid CarcinomaClinicopathologic features of familial nonmedullary thyroid carcinoma.Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid CarcinomaProspective screening in familial nonmedullary thyroid cancer.Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?Prophylactic thyroidectomy: who needs it, when, and why.Hereditary thyroid cancer syndromes and genetic testing.The impact of family history on non-medullary thyroid cancer.Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study.Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.Oncogenesis of Thyroid Cancer2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinomaFamilial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families.Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.Clinical Analysis of Familial Nonmedullary Thyroid Carcinoma.Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease.
P2860
Q26829349-1CE27CA8-FE40-4A75-A6FB-C3218BF18A53Q30367068-C125CC3A-6149-4749-B8ED-55D6F36A449DQ31036739-462C5802-E9F5-400F-9036-E364EABFEC8DQ34160828-58105C13-321F-42FA-9530-9B7F700DEC1CQ34420854-9C4DCB7F-EC86-41E0-9DA0-1B5C69DF7E96Q35218954-FF9E42B9-973D-44DF-B5ED-25ACDE74CF7FQ35233466-22FDE6C9-0234-48FE-A497-7BF52FE32A6BQ35449938-C9C7EEFA-0191-434F-97F1-372CE3688872Q35860194-F97F577C-2CA0-46BA-9EE0-DB521B97140EQ36035930-020550DB-7649-4B78-9210-6422B170E4AFQ36472626-0F96B888-B608-4383-8F16-958D04AFDF19Q36705459-E9E4328B-FF3C-4E15-86F3-3316C04E9589Q36801422-729A4DAE-9862-4D8A-8B0C-42EF25439CCEQ37377544-909DC934-095E-4F78-B202-CBBD3818167FQ37379366-096298AC-0657-4358-86F6-487F86EEC71BQ37691819-BB760541-109B-4BDA-B901-D001FE6A5EE4Q38223275-77D3D459-B55E-48D1-9BB4-C5DE5C0C3EEEQ38263389-950FCD1D-C339-46F2-95A6-2DE438CBE768Q38937305-95179F4D-890F-4B31-B85E-BEA32D6FD6DCQ38941691-6783080B-7EF5-4694-9B04-20A29AC4E40FQ38950090-1C6AC19F-CF22-4DD5-A52F-4DBD19B42E51Q39257903-05F3DBA0-811A-4DBA-A061-D6BECD8DD2BBQ40257700-AEEE0D45-828E-407A-AFE6-E115C1E0E8A5Q41039227-B5E4380D-06DB-4AB5-AD25-7906EF9A92C5Q41381572-22652B18-9986-43F3-8C9E-7594F26F87EDQ41514177-8B3B5C73-589B-46DB-B298-F294C2414D81Q42093605-B1F7EDDC-8AFE-42E3-8EDC-E81937122FB3Q44805638-31250D7B-23B2-4A84-BDEF-C5419A9EF244Q47929415-750894F1-8B9E-4AE7-B54B-29A53290ACC2Q54338447-499FE1C1-C93B-4F40-9B81-C95DCF1CA937
P2860
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@ast
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@en
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@nl
type
label
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@ast
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@en
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@nl
prefLabel
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@ast
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@en
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@nl
P2093
P2860
P356
P1433
P1476
Prevalence, clinicopathologic ...... c nonmedullary thyroid cancer.
@en
P2093
Electron Kebebew
Julie Weng
Willieford Moses
P2860
P304
P356
10.1089/THY.2010.0256
P577
2010-12-29T00:00:00Z